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To the editor: 
We would like to thank Roberts et al. for their com-
ments on our paper entitled ‘Laboratory-based surveil-
lance in the molecular era: the TYPENED model, a joint 
data-sharing platform for clinical and public health 
laboratories’ [1]. We fully agree with the remarks on 
the potential strength of adding more advanced ana-
lytical tools once the molecular surveillance network is 
established. In fact, this is what we have done previ-
ously, as part of studies of the evolution of noroviruses 
and enteroviruses [2,3]. For enteroviruses, we focused 
those studies on enterovirus 71 (EV71), for the reasons 
mentioned by Roberts et al. We compared the evolu-
tionary trajectory of EV71 in the Netherlands with that 
from a systematic collection of EV71 strains detected 
in southern China. This analysis showed a clear dif-
ference in the circulating strains, with evidence that 
the EV71 subgenogroups B and C circulating in Asia 
have evolved further than those in Europe and the 
United States [3,4]. The severity of outbreaks of EV71 
infection associated with the EV71 lineages circulat-
ing in Asia raises the question if these viruses need 
to be regarded as an emerging public health problem 
[5].  The analysis also showed that previous peaks in 
reporting reflected true epidemics [3]. Further stud-
ies showed that recombination was part of the driv-
ing force for those epidemics [6].  We agree that such 
studies give a much deeper understanding of the 
epidemiology of enteroviruses, and would strongly 
support its development in an international context. 
The rapid transition from culture-based diagnostic 
methods to molecular diagnostics in clinical virology 
in our country was a trigger to do this, and will most 
likely also affect other surveillance systems such as 
those for influenza or food-borne bacterial pathogens 
[7]. However, at present, this transition has not been 
made in most countries globally. Our article aimed to 
describe the model applied in the Netherlands for an 
approach to molecular surveillance, in which clinical 
and public health laboratories collaborate by defining 
common goals. This model was developed to facilitate 
the transition, and includes comparative evaluation of 
surveillance trends obtained by classical and molecu-
lar virological methods 1.  If outcomes are agreed 
upon, we will further develop the system, which would 
include the more advanced analytical approaches sug-
gested by Roberts et al.
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